A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
NCT04052932
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
594
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
SHR4640 dose1
DRUG:
SHR4640 dose2
DRUG:
Placebo oral tablet
DRUG:
Allopurinol 300 MG
Sponsor
Jiangsu HengRui Medicine Co., Ltd.